BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Samanta A, Sen Sarma M. Metabolic dysfunction-associated steatotic liver disease: A silent pandemic. World J Hepatol 2024; 16(4): 511-516 [PMID: 38689742 DOI: 10.4254/wjh.v16.i4.511]
URL: https://www.wjgnet.com/1948-5182/full/v16/i4/511.htm
Number Citing Articles
1
М. В. Турчин, І. М. Кліщ. ВПЛИВ ЛІПІДНОГО ТА ВУГЛЕВОДНОГО ОБМІНУ НА СТРУКТУРНІ ЗМІНИ ОКА У ПАЦІЄНТІВ РІЗНОЇ СТАТІMedical and Clinical Chemistry 2024; (2): 12 doi: 10.11603/mcch.2410-681X.2024.i2.14762
2
Alan C. Logan, Susan L. Prescott, Erica M. LaFata, Jeffrey J. Nicholson, Christopher A. Lowry. Beyond Auto-Brewery: Why Dysbiosis and the Legalome Matter to Forensic and Legal PsychologyLaws 2024; 13(4): 46 doi: 10.3390/laws13040046
3
Laura Žigutytė, Thomas Sorz-Nechay, Jan Clusmann, Jakob Nikolas Kather. Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024JHEP Reports 2024; 6(12): 101209 doi: 10.1016/j.jhepr.2024.101209
4
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya. Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A ReviewPreventive Medicine: Research & Reviews 2025; 2(4): 183 doi: 10.4103/PMRR.PMRR_159_24
5
Ryan J. Dashek, Taylor J. Kelty, Rory P. Cunningham, Jack Flink, Alexa A. Krause, Grace Shryack, Christopher L. Taylor, Grace M. Meers, Tadashi Yoshida, Srinivas Mummidi, Bysani Chandrasekar, R. Scott Rector. Loss of hepatocyte-specific RECK exacerbates metabolic dysfunction-associated steatohepatitisAmerican Journal of Physiology-Endocrinology and Metabolism 2025; 329(4): E537 doi: 10.1152/ajpendo.00031.2025
6
Salvatore Pezzino, Stefano Puleo, Tonia Luca, Mariacarla Castorina, Sergio Castorina. Adipokine and Hepatokines in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Current and Developing TrendsBiomedicines 2025; 13(8): 1854 doi: 10.3390/biomedicines13081854
7
Gabrielle Goddard, Shilpa Rajagopal, Gennifer Wahbah Makhoul, Mukaila A. Raji. Metabolic Syndrome in Older Adults: Through the Lens of Institute for Healthcare Improvement’s (IHI) 4Ms Framework and Social Determinants of HealthLife 2025; 15(9): 1370 doi: 10.3390/life15091370
8
Sofia Tamini, Adele Bondesan, Diana Caroli, Nicoletta Marazzi, Alessandro Sartorio. The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with ObesityJournal of Clinical Medicine 2025; 14(7): 2341 doi: 10.3390/jcm14072341
9
Marcelo do Rego Maciel Souto Maior, Nathália de Lacerda Interaminense Ribeiro, Hannah Vicentini Vitoriano Silva, Edmundo Pessoa Lopes, Emilia Chagas Costa. Metabolic Dysfunction-Associated Steatotic Liver Disease as a Risk Factor for Chronic Kidney Disease: A Narrative ReviewBiomedicines 2025; 13(9): 2162 doi: 10.3390/biomedicines13092162
10
Bin Hu, Ai-Hong Wan, Xi-Qiao Xiang, Yuan-Hao Wei, Yi Chen, Zhen Tang, Chang-De Xu, Zi-Wei Zheng, Shao-Ling Yang, Kun Zhao. Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysisWorld Journal of Hepatology 2024; 16(8): 1145-1155 doi: 10.4254/wjh.v16.i8.1145